Free Trial
LON:GSK

GSK (GSK) Share Price, News & Analysis

GSK logo
GBX 1,408.50 -46.00 (-3.16%)
As of 07/11/2025 12:47 PM Eastern

About GSK Stock (LON:GSK)

Key Stats

Today's Range
1,405
1,457
50-Day Range
1,358
1,545.94
52-Week Range
1,242.50
1,678.68
Volume
8.54 million shs
Average Volume
13.89 million shs
Market Capitalization
£57.15 billion
P/E Ratio
22.75
Dividend Yield
4.26%
Price Target
GBX 1,525
Consensus Rating
Hold

Company Overview

GSK Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

GSK MarketRank™: 

GSK scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GSK has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    GSK has only been the subject of 2 research reports in the past 90 days.

  • Read more about GSK's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GSK is 22.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.90.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GSK is 22.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.96.

  • Price to Earnings Growth Ratio

    GSK has a PEG Ratio of 1.24. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    GSK has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GSK.
  • Dividend Leadership

    GSK is a leading dividend payer. It pays a dividend yield of 4.25%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    GSK does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of GSK is 96.92%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about GSK's dividend.
  • Short Interest

    There is no current short interest data available for GSK.
  • News Sentiment

    GSK has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for GSK this week, compared to 6 articles on an average week.
  • Search Interest

    27 people have searched for GSK on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GSK insiders have sold 190.19% more of their company's stock than they have bought. Specifically, they have bought £27,328.35 in company stock and sold £79,303.77 in company stock.

  • Percentage Held by Insiders

    Only 1.61% of the stock of GSK is held by insiders.

  • Percentage Held by Institutions

    45.33% of the stock of GSK is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about GSK's insider trading history.
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Stock News Headlines

GSK plc (LON:GSK) Insider Wendy Becker Buys 545 Shares
Zantac makers handed court win in Delaware
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
GSK Enhances Shareholder Value with Strategic Buyback
GSK (LON:GSK) Receives Hold Rating from Deutsche Bank Aktiengesellschaft
See More Headlines

GSK Stock Analysis - Frequently Asked Questions

GSK's stock was trading at GBX 1,346.50 at the beginning of the year. Since then, GSK stock has increased by 4.6% and is now trading at GBX 1,408.50.

GSK plc (LON:GSK) announced its earnings results on Wednesday, April, 30th. The company reported $44.90 earnings per share for the quarter. GSK had a trailing twelve-month return on equity of 18.08% and a net margin of 8.02%.

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that GSK investors own include AstraZeneca (AZN), Vodafone Group Public (VOD), Lloyds Banking Group (LLOY), Secure Trust Bank (STB), Barclays (BARC), Meta Platforms (META) and Intel (INTC).

Company Calendar

Last Earnings
4/30/2025
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:GSK
CIK
N/A
Fax
N/A
Employees
70,212
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 1,600
Low Price Target
GBX 1,450
Potential Upside/Downside
+8.3%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 61.91
Trailing P/E Ratio
22.75
Forward P/E Ratio
8.00
P/E Growth
1.24
Net Income
£2.50 billion
Net Margins
8.02%
Pretax Margin
N/A
Return on Equity
18.08%
Return on Assets
9.56%

Debt

Debt-to-Equity Ratio
114.64
Current Ratio
0.81
Quick Ratio
0.73

Sales & Book Value

Annual Sales
£31.14 billion
Price / Sales
1.84
Cash Flow
GBX 172.92 per share
Price / Cash Flow
8.15
Book Value
GBX 329.73 per share
Price / Book
4.27

Miscellaneous

Outstanding Shares
4,057,829,779
Free Float
N/A
Market Cap
£57.15 billion
Optionable
Not Optionable
Beta
0.31
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:GSK) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners